BIO-key International, Inc. (NASDAQ:BKYI) Short Interest Down 36.3% in April

BIO-key International, Inc. (NASDAQ:BKYI) was the target of a significant decrease in short interest during the month of April. As of April 15th, there was short interest totalling 54,300 shares, a decrease of 36.3% from the March 31st total of 85,300 shares. Currently, 2.7% of the shares of the stock are short sold. Based on an average daily volume of 281,000 shares, the days-to-cover ratio is currently 0.2 days.

BIO-key International Trading Down 6.8 %

Shares of BIO-key International stock opened at $0.74 on Tuesday. BIO-key International has a 1 year low of $0.52 and a 1 year high of $3.68. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.78 and a quick ratio of 0.71. The business has a 50 day moving average price of $0.90 and a 200 day moving average price of $1.09. The company has a market capitalization of $2.31 million, a P/E ratio of -0.33 and a beta of 0.49.

BIO-key International (NASDAQ:BKYI) last released its quarterly earnings results on Thursday, March 27th. The technology company reported ($0.53) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.18). The company had revenue of $1.46 million during the quarter, compared to analyst estimates of $2.29 million. BIO-key International had a negative return on equity of 3,124.77% and a negative net margin of 72.53%.

BIO-key International Company Profile

BIO-key International, Inc develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.